Sign in
CRDL Stock Price, Chart, Stats & News
Cardiol Therapeutics Inc.
Save
Cardiol Therapeutics Inc. (CRDL) does not currently pay a dividend.
127.95M
Market cap
–
Current P/E
–
Forward P/E
CRDL chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -249.38% |
ROE | -202.81% |
D/E | 0.01x |
Interest coverage ratio | – |
CRDL valuation
P/E | – |
P/S | – |
P/B | 15.38x |
P/CF | -6.07x |
P/FCF | -7.99x |
P/OCF | -6.07x |
PEG | -0.27x |
EV multiple | -6.49x |
About
Cardiol Therapeutics Inc. is a clinical-stage life sciences firm dedicated to discovering and advancing anti-fibrotic and anti-inflammatory therapies for cardiovascular disease (CVD). Its leading candidate, CardiolRx, is currently undergoing a multi-national, randomized, double-blind, placebo-controlled Phase II/III study. This pivotal trial assesses CardiolRx's safety and effectiveness as a cardioprotective treatment to diminish cardiovascular and respiratory complications in hospitalized COVID-19 patients, while also investigating its potential for acute myocarditis.
Similar securities
Based on sector and market capitalization
Report issue